S1P1

A board to discuss future MS therapies in early stage (Phase I or II) trials.

S1P1

Postby scorpion » Thu Jan 27, 2011 10:23 am

Receptos Initiates Clinical Trials for S1P1 Agonist Program, Aimed at Multiple Sclerosis <shortened url>
User avatar
scorpion
Family Elder
 
Posts: 1323
Joined: Wed Nov 05, 2008 4:00 pm

Advertisement

Postby patientx » Thu Jan 27, 2011 4:22 pm

Sounds a lot like Gilenya.
User avatar
patientx
Family Elder
 
Posts: 1068
Joined: Wed Sep 10, 2008 3:00 pm

Postby dignan » Thu Jan 27, 2011 9:26 pm

Thanks for the info Scorpion. I agree patientx. I don't know if that's good or bad. On the bright side, it appears to be a worthwhile target. On the other hand, is there any reason to believe this will be better than gilenya?
User avatar
dignan
Family Elder
 
Posts: 1608
Joined: Wed Aug 11, 2004 3:00 pm

Postby rainer » Thu Jan 27, 2011 11:03 pm

If nothing else, maybe it will reduce the price gouging going on.
User avatar
rainer
Family Elder
 
Posts: 367
Joined: Thu Jan 17, 2008 4:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron